Cargando…

Altered Peroxisome-Proliferator Activated Receptors Expression in Human Endometrial Cancer

Peroxisome proliferator-activated receptors (PPARs) belong to a family of nuclear hormone receptors acting as transcriptional factors, recently involved also in carcinogenesis. Present study was undertaken to evaluate the presence and subcellular localization of different PPAR isoforms (α, β, γ) in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knapp, Paweł, Chabowski, Adrian, Błachnio-Zabielska, Agnieszka, Jarząbek, Katarzyna, Wołczyński, Sławomir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289929/ https://www.ncbi.nlm.nih.gov/pubmed/22448166 http://dx.doi.org/10.1155/2012/471524

Ejemplares similares

Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology
por: Jarzabek, Katarzyna, et al.
Publicado: (2013)

Blood bioactive sphingolipids in patients with advanced serous epithelial ovarian cancer – mass spectrometry analysis
por: Knapp, Paweł, et al.
Publicado: (2018)

The Impact of OMEGA-3 Fatty Acids Supplementation on Insulin Resistance and Content of Adipocytokines and Biologically Active Lipids in Adipose Tissue of High-Fat Diet Fed Rats
por: Chacińska, Marta, et al.
Publicado: (2019)

Maternal Plasma and Amniotic Fluid Sphingolipids Profiling in Fetal Down Syndrome
por: Charkiewicz, Karol, et al.
Publicado: (2015)

Effect of plasma free fatty acid supply on the rate of ceramide synthesis in different muscle types in the rat
por: Zabielski, Piotr, et al.
Publicado: (2017)

The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer
por: Psilopatis, Iason, et al.
Publicado: (2023)

Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat
por: Knapp, Małgorzata, et al.
Publicado: (2012)

Sphingolipids as a new factor in the pathomechanism of preeclampsia – Mass spectrometry analysis
por: Charkiewicz, Karol, et al.
Publicado: (2017)

The DAX1 mutation in a patient with hypogonadotropic hypogonadism and adrenal hypoplasia congenita causes functional disruption of induction of spermatogenesis
por: Ponikwicka-Tyszko, Donata, et al.
Publicado: (2012)

The Role of Ceramides in Insulin Resistance
por: Sokolowska, Emilia, et al.
Publicado: (2019)

Exercise increases sphingoid base-1-phosphate levels in human blood and skeletal muscle in a time- and intensity-dependent manner
por: Baranowski, Marcin, et al.
Publicado: (2014)

Assessment of FSHR, AMH, and AMHRII variants in women with polycystic ovary syndrome
por: Czeczuga-Semeniuk, Ewa, et al.
Publicado: (2014)

A Critical Review of Electroporation as A Plasmid Delivery System in Mouse Skeletal Muscle
por: Sokołowska, Emilia, et al.
Publicado: (2019)

Gestational diabetes mellitus is associated with increased leukocyte peroxisome proliferator-activated receptor γ expression
por: Wójcik, Marzena, et al.
Publicado: (2015)

The Influence of the Differentiation of Genes Encoding Peroxisome Proliferator-Activated Receptors and Their Coactivators on Nutrient and Energy Metabolism
por: Maciejewska-Skrendo, Agnieszka, et al.
Publicado: (2022)

Obesity, Bioactive Lipids, and Adipose Tissue Inflammation in Insulin Resistance
por: Kojta, Iwona, et al.
Publicado: (2020)

The Influence of Physical Activity on the Bioactive Lipids Metabolism in Obesity-Induced Muscle Insulin Resistance
por: Imierska, Monika, et al.
Publicado: (2020)

The Role of Obesity, Inflammation and Sphingolipids in the Development of an Abdominal Aortic Aneurysm
por: Okrzeja, Jakub, et al.
Publicado: (2022)

Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations
por: Espinosa-Jiménez, Triana, et al.
Publicado: (2022)

Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
por: Nishida, K., et al.
Publicado: (2008)

Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma
por: Park, Hyung Kyu, et al.
Publicado: (2015)

Editorial: The Role of Sphingolipid Metabolism in the Development of Type 2 Diabetes and Obesity
por: Blachnio-Zabielska, Agnieszka, et al.
Publicado: (2022)

Expression of the Peroxisome Proliferator-Activated Receptors (PPARs) in the Hepatic Stellate Cells
por: Sato, Takeya, et al.
Publicado: (2004)

Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance
por: Blachnio-Zabielska, Agnieszka U., et al.
Publicado: (2012)

Peroxisome Proliferator-Activated Receptors in Lung Cancer
por: Keshamouni, Venkateshwar G., et al.
Publicado: (2007)

Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
por: Kersten, Sander
Publicado: (2008)

Peroxisome Proliferator-Activated Receptors in Diabetic Nephropathy
por: Kume, Shinji, et al.
Publicado: (2008)

Peroxisome Proliferator-Activated Receptors and Shock State
por: Esposito, Emanuela, et al.
Publicado: (2006)

Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer
por: Wagner, Nicole, et al.
Publicado: (2022)

The Role of Peroxisome Proliferator-Activated Receptors in Preeclampsia
por: Psilopatis, Iason, et al.
Publicado: (2023)

Osteoarthritis: Role of Peroxisome Proliferator-Activated Receptors
por: Sheng, Weibei, et al.
Publicado: (2023)

Aerobic Training in Rats Increases Skeletal Muscle Sphingomyelinase and Serine Palmitoyltransferase Activity, While Decreasing Ceramidase Activity
por: Błachnio-Zabielska, Agnieszka, et al.
Publicado: (2010)

Adipose-Derived Exosomes as Possible Players in the Development of Insulin Resistance
por: Żbikowski, Arkadiusz, et al.
Publicado: (2021)

Peroxisome proliferator-activated receptor γ agonist suppresses human telomerase reverse transcriptase expression and aromatase activity in eutopic endometrial stromal cells from endometriosis
por: Chang, Hye Jin, et al.
Publicado: (2013)

Enhanced Hepatocarcinogenicity Due to Agonists of Peroxisome Proliferator-Activated Receptors in Senescent Rats: Role of Peroxisome Proliferation, Cell Proliferation, and Apoptosis
por: Youssef, Jihan, et al.
Publicado: (2002)

Altered Peroxisome Proliferator-Activated Receptor Alpha Signaling in Variably Diseased Peripheral Arterial Segments
por: Engel, Connor, et al.
Publicado: (2022)

Association between the Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor Gamma Gene and Strength Athlete Status
por: Maciejewska-Karlowska, Agnieszka, et al.
Publicado: (2013)

Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
por: Fruchart, Jean-Charles
Publicado: (2013)

Energy Substrate Transporters in High-Grade Ovarian Cancer: Gene Expression and Clinical Implications
por: Baczewska, Marta, et al.
Publicado: (2022)

Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma
por: Zhang, G Y, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_jum4rq4mke858holtmdvkl04ol